Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiota-Derived SCFAs Mediate the Synergistic Antidepressant Effects of Dajianzhong Decoction and Ketamine via FFAR2-NLRP3-IL-1β Signaling.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Heterogeneity in risk and potential pathogenic associations of NAFLD among distinct prediabetic phenotypes in young and middle-aged adults.

Frontiers in endocrinology·2026
Same author

BCL-XL drives fibrotic and leukemic progression in myeloproliferative neoplasms.

Frontiers in immunology·2026
Same author

Systematic review with network meta-analysis: efficacy and safety of minimally invasive interventions for symptomatic uterine fibroids.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2026
Same author

Disrupting the physical interaction between serotonin transporter and soluble guanylate cyclase produces a fast-acting antidepressant activity.

Pharmacological research·2026
Same author

Endocrine Disorders Associated with Sevoflurane: A Real-World Pharmacovigilance Study Based on the FAERS Database.

The Tohoku journal of experimental medicine·2026
Same journal

Endogenous-metabolite-inspired polyamine-oleic acid lipids for safe mRNA delivery and PCSK9 gene editing.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Tunable rigid spikes on virus-like porous silica enable mechanistically controlled nanovaccine platforms.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

A cation-free platform based on azocalixarene poly(disulfide)s for direct cytosolic protein delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Harnessing plant-derived extracellular vesicles for oral delivery: A dual role as natural therapeutics and engineered drug carriers.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K

A preparation method for mRNA-LNPs with improved properties.

Cong Geng1, Kefan Zhou1, Ying Yan2

  • 1School of Pharmacy, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang 050017, PR China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|November 13, 2023
PubMed
Summary
This summary is machine-generated.

A novel Two-step tangential-flow filtration (TFF) method enhances messenger RNA lipid nanoparticle (mRNA-LNP) preparation. This technique improves LNP properties like stability and transfection efficiency, paving the way for broader clinical applications.

Keywords:
Empty lipid nanoparticlesEthanol removalLipid nanoparticlesParticle fusionStability

More Related Videos

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

11.4K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K

Related Experiment Videos

Last Updated: Jul 11, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

11.4K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Drug Delivery

Background:

  • Messenger RNA lipid nanoparticles (mRNA-LNPs) are crucial for various therapeutic applications.
  • The efficacy and safety of mRNA-LNPs are significantly influenced by their physicochemical properties.
  • Preparation methods directly impact critical parameters such as size, purity, stability, and potency.

Purpose of the Study:

  • To introduce and evaluate a novel Two-step tangential-flow filtration (TFF) method for mRNA-LNP preparation.
  • To investigate the impact of this improved method on key mRNA-LNP characteristics.
  • To assess the potential of the optimized mRNA-LNPs for industrial applicability and clinical use.

Main Methods:

  • Implementation of a Two-step tangential-flow filtration (TFF) process for mRNA-LNP production.
  • Inclusion of an additional ethanol removal step before particle fusion.
  • Characterization of mRNA-LNPs for size, empty particle content, morphology, storage stability, and in vitro transfection efficiency.
  • Evaluation of in vivo biodistribution, particularly in the heart and blood.

Main Results:

  • The Two-step TFF method successfully produced larger mRNA-LNPs.
  • A significant reduction in the proportion of empty LNPs was observed.
  • Optimized storage stability was achieved, maintaining integrity for at least 6 months at 2-8 °C.
  • Enhanced in vitro transfection efficiency and improved in vivo biodistribution with minimized cardiac and blood accumulation were demonstrated.

Conclusions:

  • The Two-step TFF method offers a significant advancement in mRNA-LNP preparation.
  • This method enhances critical mRNA-LNP properties, including purity, stability, and efficacy.
  • The optimized mRNA-LNPs show promise for improved industrial scalability and expanded clinical applications.